MHR
UBX

Matthew Hamilton Rosenberg’s Unity Biotechnology UBX Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$548 – 946
2022
Q4 		$548 Hold
200
– – ﹤0.01% 861
2022
Q3 		$1K Hold
200
– – ﹤0.01% 840
2022
Q2 		$1K Hold
200
– – ﹤0.01% 782
2022
Q1 		$2K Hold
200
– – ﹤0.01% 720
2021
Q4 		$3K Hold
200
– – ﹤0.01% 675
2021
Q3 		$6K Hold
200
– – ﹤0.01% 624
2021
Q2 		$9K Hold
200
– – ﹤0.01% 525
2021
Q1 		$12K Buy
+200
New +$13.6K 0.01% 479

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Matthew Hamilton Rosenberg's UBX Position: Q1 2023 in Review

Matthew Hamilton Rosenberg sold out of Unity Biotechnology (UBX) in Q1 2023, closing a stake of 200 shares — an estimated $548 sold.

Matthew Hamilton Rosenberg first reported a position in UBX in Q1 2021 and held it in 8 quarters. The position peaked at $12K in Q1 2021. 46 funds tracked by Wall St. Rank hold UBX as of Q1 2023.

  • Matthew Hamilton Rosenberg reported no remaining Unity Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 200 Unity Biotechnology shares in Q1 2023, an estimated $548.
  • Matthew Hamilton Rosenberg first reported a position in Unity Biotechnology in Q1 2021 and held it in 8 quarters.
  • Matthew Hamilton Rosenberg's Unity Biotechnology position peaked at $12K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2023.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2023, filed 17 Apr 2023.